Deze vertaling wordt voorbereid. Voorlopig tonen we de oorspronkelijke Engelse versie.
Bedrijven · 20-5-20241 min lezen
Prospective Grant of an Exclusive Patent License: T Cell Receptor Fusion Proteins for the Treatment of Cancer
Lokale automatische vertaling · Oorspronkelijke brontaal
Samenvatting
The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the Patents and Patent Applications listed in the Supplementary Information section of this notice to INTcRON LLC ("INTcRON") located in Memphis, Tennessee.
Oorspronkelijke brontaal: Federal Register — Health and Human ServicesOrigineel bericht openen →